Stryker (SYK) Competitors $364.60 +7.46 (+2.09%) (As of 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SYK vs. ABT, ISRG, BSX, MDT, BDX, EW, IDXX, RMD, DXCM, and STEShould you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Stryker vs. Abbott Laboratories Intuitive Surgical Boston Scientific Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Abbott Laboratories (NYSE:ABT) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Is ABT or SYK a better dividend stock? Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 2.1%. Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 0.9%. Abbott Laboratories pays out 71.7% of its earnings in the form of a dividend. Stryker pays out 36.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Abbott Laboratories has increased its dividend for 53 consecutive years and Stryker has increased its dividend for 32 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has better valuation and earnings, ABT or SYK? Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.22B4.78$5.72B$3.2934.55Stryker$21.97B6.23$3.17B$9.3338.46 Do institutionals and insiders have more ownership in ABT or SYK? 75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 1.1% of Abbott Laboratories shares are held by company insiders. Comparatively, 5.9% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate ABT or SYK? Abbott Laboratories currently has a consensus price target of $130.71, indicating a potential upside of 14.98%. Stryker has a consensus price target of $405.80, indicating a potential upside of 13.09%. Given Abbott Laboratories' higher probable upside, equities research analysts plainly believe Abbott Laboratories is more favorable than Stryker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.73Stryker 0 Sell rating(s) 3 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.85 Does the media favor ABT or SYK? In the previous week, Abbott Laboratories had 3 more articles in the media than Stryker. MarketBeat recorded 16 mentions for Abbott Laboratories and 13 mentions for Stryker. Stryker's average media sentiment score of 1.04 beat Abbott Laboratories' score of 0.88 indicating that Stryker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 8 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stryker 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ABT or SYK? Abbott Laboratories has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Does the MarketBeat Community believe in ABT or SYK? Abbott Laboratories received 11 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 69.70% of users gave Abbott Laboratories an outperform vote while only 64.77% of users gave Stryker an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes93469.70% Underperform Votes40630.30% StrykerOutperform Votes92364.77% Underperform Votes50235.23% Is ABT or SYK more profitable? Stryker has a net margin of 16.34% compared to Abbott Laboratories' net margin of 13.99%. Stryker's return on equity of 23.07% beat Abbott Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories13.99% 20.18% 10.84% Stryker 16.34%23.07%11.04% SummaryStryker beats Abbott Laboratories on 13 of the 21 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Stryker News Delivered to You Automatically Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYK vs. The Competition Export to ExcelMetricStrykerSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$136.80B$4.30B$4.98B$19.01BDividend Yield0.86%41.45%4.87%3.54%P/E Ratio38.4625.18135.1640.91Price / Sales6.2344.431,157.0316.41Price / Cash27.9443.4640.5521.28Price / Book7.337.274.735.27Net Income$3.17B$13.83M$118.55M$988.46M7 Day Performance-4.25%-4.59%-2.45%-4.30%1 Month Performance-6.96%-1.33%11.31%-3.23%1 Year Performance24.46%42.22%30.51%12.90% Stryker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYKStryker4.9656 of 5 stars$364.60+2.1%$405.80+11.3%+22.3%$138.99B$21.97B39.0852,000Analyst ForecastPositive NewsHigh Trading VolumeABTAbbott Laboratories4.9055 of 5 stars$113.49+0.1%$130.71+15.2%+3.7%$196.84B$41.22B34.46114,000Dividend IncreaseISRGIntuitive Surgical4.6725 of 5 stars$546.64+1.3%$550.28+0.7%+56.1%$194.70B$7.87B86.7513,676Analyst ForecastBSXBoston Scientific4.3969 of 5 stars$91.14+1.1%$95.52+4.8%+58.8%$134.32B$15.91B75.0248,000Analyst ForecastMDTMedtronic4.9488 of 5 stars$82.06-0.5%$95.27+16.1%-2.5%$105.22B$33.00B25.1495,000Analyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9076 of 5 stars$230.54+2.2%$283.50+23.0%-7.0%$66.65B$20.18B37.9774,000Analyst DowngradeInsider TradeAnalyst RevisionEWEdwards Lifesciences3.9144 of 5 stars$73.57+0.3%$79.40+7.9%-1.8%$43.39B$6.00B10.7419,800IDXXIDEXX Laboratories4.9817 of 5 stars$432.35+0.1%$539.63+24.8%-25.0%$35.40B$3.84B41.6711,000Positive NewsRMDResMed4.5161 of 5 stars$241.02+1.0%$227.91-5.4%+33.4%$35.38B$4.81B31.599,980Positive NewsDXCMDexCom4.9106 of 5 stars$76.42-1.0%$98.00+28.2%-38.5%$29.85B$3.95B46.229,600STESTERIS4.9319 of 5 stars$213.74-0.2%$262.50+22.8%-6.7%$21.10B$5.14B48.9118,179Positive News Related Companies and Tools Related Companies ABT Alternatives ISRG Alternatives BSX Alternatives MDT Alternatives BDX Alternatives EW Alternatives IDXX Alternatives RMD Alternatives DXCM Alternatives STE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:SYK) was last updated on 12/20/2024 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMusk threatens Liberal’s fake “energy crisis”Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people a...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
